Haleon plc (NYSE: HLN) is a global consumer healthcare company headquartered in Weybridge, England. The company develops, manufactures and markets over-the-counter medicines, oral healthcare products, nutritional supplements and other consumer health products sold through pharmacies, retailers and e-commerce channels.
Its portfolio includes well-known brands such as Sensodyne, Polident and parodontax in oral healthcare; Advil, Panadol, Voltaren and Theraflu in pain relief and respiratory care; and Centrum and Emergen-C in vitamins, minerals and supplements. Haleon also markets products for digestive health, skin health and other everyday healthcare needs.
Haleon was created through the demerger of GSK’s consumer healthcare business and began operating as an independent public company in July 2022. It serves consumers in markets around the world, with products distributed across North America, Europe, Asia-Pacific, Latin America, Africa and other international regions. Its business is focused on helping consumers manage common health conditions and support daily wellness through accessible, nonprescription products.
AI Generated. May Contain Errors.
